Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

{{ error }}

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Please Try Again

{{ error }}

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

or

Privacy Policy | Disclaimer

Quote | Bullboard | News | Opinion | Profile | Peers | Filings | Financials | Options | Price History | Ratios | Ownership | Insiders | Valuation

Breaking & Recent News Terumo Ord Shs TRUMF

Alternate Symbol(s): TRUMY

Healthcare Medical Devices

TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The... see more

Add To Watchlist

Recent & Breaking News (PINL:TRUMF)

Terumo Blood and Cell Technologies and CSL Plasma Announce Collaboration to Deliver New Plasma Collection Platform

PR Newswire April 19, 2021

Terumo Signs a Definitive Agreement to Acquire All Assets of Health Outcomes Sciences, Inc.

PR Newswire February 23, 2021

Lower-Profile Web Intrasaccular Aneurysm Treatment Device Receives FDA Approval

PR Newswire January 12, 2021

MicroVention, Inc. Files Trade Secret Lawsuit Against Balt USA, LLC

PR Newswire December 23, 2020

IceCure Expands Strategic Collaboration with Terumo: New Commercial Distribution Agreement Potentially Valued at over $7.0 Million

PR Newswire October 5, 2020

MicroVention-Terumo Announces New Leadership

PR Newswire September 22, 2020

Terumo Cardiovascular and CytoSorbents Collaborate to Commercialize CytoSorb® in Ten U.S. Hotspot States under Emergency Use Authorization for COVID-19

PR Newswire August 24, 2020

Terumo Acquires Quirem Medical to Enhance Its Interventional Oncology Field

Canada NewsWire July 15, 2020

MicroVention Announces FDA Premarket Approval of a New Flow Diverter for the Treatment of Brain Aneurysms

PR Newswire January 9, 2020

Terumo Enhances Coronary Interventional Product Portfolio By Securing Exclusive Global Rights to Orchestra BioMed's Virtue® Sirolimus-Eluting Balloon (SEB) through Global Strategic Partnership

PR Newswire June 13, 2019

MicroVention Announces Positive Safety And Effectiveness Results In Web-It Pivotal Trial Published In Journal Of NeuroInterventional Surgery

PR Newswire April 18, 2019

Terumo Cardiovascular Group and Talis Clinical Announce Partnership to Deliver Intelligent, Real-Time Guidances to CVOR and CVICU to Improve Outcomes

PR Newswire January 23, 2019

Novel Intrasaccular Aneurysm Treatment Device Receives FDA PMA Approval

PR Newswire January 7, 2019

Terumo Cardiovascular Group Announces 510(k) Clearance for the CDI® Blood Parameter Monitoring System 550, Adding New Parameter for Oxygen Delivery

PR Newswire November 14, 2018

MicroVention Announces FDA Clearance For Thrombectomy Device

PR Newswire June 12, 2018

MicroVention® Announces FDA Approval For Neuro Stent Device

PR Newswire May 31, 2018

Medeon Entering Asset Purchase Agreement with Terumo for its Large Bore Vascular Closure System

PR Newswire March 5, 2018

MicroVention Celebrates Grand Opening Of New Worldwide Innovation Center In Aliso Viejo, California

PR Newswire September 26, 2017

Terumo Cardiovascular Group Announces New President and CEO, Robert DeRyke

PR Newswire April 6, 2017

Terumo Showcases Radial Access Portfolio at American College of Cardiology Conference

PR Newswire March 17, 2017